Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Tirzepatide is a related medication that works on both GLP-1 and GIP receptors and requires similar monitoring
Retatrutide is developed by Eli Lilly, the company behind tirzepatide (Mounjaro/Zepbound)
Novel unimolecular, multifunctional peptides have emerged as one of the most promising medicinal approaches to enhance metabolic efficacy and restore normal body weight
Obesity Causes and Risk Factors Obesity is a multifaceted illness with several causes [3] as elaborated in blue-dotted lines in Fig
It primarily targets the melanocortin 1 receptor (MC1R) on melanocytes
Full Certificates of Analysis are available upon request for every batch before release
US$ 21.25
US$ 27.26
US$ 28.55
